Carving a Path Toward Pragmatic Innovation in Clinical Trials
Prioritizing risk-based management, data science, smart automation, standards, and patient optionality are critical for the industry to keep up with market changes. The recent FDA guidance that encourages ‘pragmatic trials’ in specific scenarios is a move in the right direction.
The Future of Glucose Monitoring: Why Blood-Based Measurements Matter
Today, people living with diabetes have several ways of monitoring glucose levels, whether through finger pricks or CGMs. Both ways of measuring glucose levels have benefits and limitations.
New AMA Report Highlights Lack of Competition in PBM Market
In a new analysis, the American Medical Association detailed the lack of competition among pharmacy benefit managers and their high level of vertical integration with insurers.
What Do Digital Health Leaders Think of Trump’s New AI Action Plan?
In a new action plan, the White House aims to boost the country’s AI innovation through deregulation, infrastructure expansion and new incentives. Overall, the move is welcomed by healthcare AI leaders — but they did notice some omissions, including AI safety, patient consent and the role of key healthcare regulators.
White Bagging: A Prescription for Disruption in Care
White bagging not only creates significant uncompensated administrative burden and scheduling challenges for providers, but it also delays or limits access to necessary medication for patients.